Change request 10901 updates the "Medicare Program Integrity Manual" with detailed changes to the local coverage determination (LCD) process, which will help to increase transparency, clarity, consistency, reduce provider burden, and enhance public relations while retaining the ability to be responsive to local clinical and coverage policy concerns. [MM10901]
So coding changes can be made more efficiently without requiring reconsideration of an LCD, CPT® and ICD-10 codes are being relocated from LCDs to associated billing and coding articles or policy articles. [CR10901]
Based on change request (CR) 10901, the local coverage determination for 3D interpretation and reporting of imaging studies was revised to remove all current procedural terminology (CPT®) and ICD-10–CM diagnosis codes and place them into a newly created billing and coding article.
Based on change request (CR) 11295, the local coverage determination for intravenous immune globulin, was revised to add ICD-10-CM diagnoses codes to the "ICD-10 Codes that Support Medical Necessity/Group 1 codes."
Based on change request (CR) 10901, the local coverage determination for vitamin D; 25 hydroxy, includes fractions(s), if performed, was revised to remove all current procedural terminology (CPT®) and ICD-10–CM diagnosis codes and place them into a newly created billing and coding article.
Based on review of the local coverage determination, and related billing and coding article for sacral neuromodulation, typographical errors were identified and corrected.
Based on CR 10901, the local coverage determination, for YAG laser capsulotomy, was revised to remove all billing and coding and place into a newly created billing and coding article.
Based on review of the local coverage determination, and related billing and coding article for E&M home and domiciliary visits, typographical errors were identified and corrected.
Based on review of the local coverage determination (LCD) for monitored anesthesia care (MAC) for certain interventional pain management services, the LCD will be retired.
Based on change request (CR) 10901, the local coverage determination for urinary tumor markers for bladder cancer was revised to remove all current procedural terminology (CPT®) and ICD-10–CM diagnosis codes and place them into a newly created billing and coding article.
Based on change request (CR) 10901, the local coverage determination for intensity modulated radiation therapy (IMRT) was revised to remove all current procedural terminology (CPT®) and ICD-10–CM diagnosis codes and place them into a newly created billing and coding article.
Please review these quick tips from the durable medical equipment Medicare administrative contractor (DME MAC) about ordering oxygen and oxygen equipment for your Medicare patients.
Based on review of the local coverage determination (LCD) for screening and diagnostic mammography, the LCD and related coding guidelines is being retired.
Based on change request (CR) 10901, the local coverage determination for wireless capsule endoscopy was revised to remove all current procedural terminology (CPT®) and ICD-10–CM diagnosis codes and place them into a newly created billing and coding article.
Based on change request (CR) 10901, the local coverage determination for label and off-label coverage of outpatient drugs and biologicals was revised to remove all current procedural terminology (CPT®) and ICD-10–CM diagnosis codes and place them into a newly created billing and coding article.
Based on change request (CR) 10901, the local coverage determination for vascular endothelial growth factor inhibitors for the treatment of ophthalmological diseases was revised to remove all current procedural terminology (CPT®) and ICD-10–CM diagnosis codes and place them into a newly created billing and coding article.
Based on change request (CR) 10901, the local coverage determination for trastuzumab was revised to remove all current procedural terminology (CPT®) and ICD-10–CM diagnosis codes and place them into a newly created billing and coding article.
This calculator will assist you in determining when additional documentation requested by First Coast Service Options Inc. (First Coast) must be received.
First Coast has implemented a new process to reduce provider burden and process claims more efficiently. If you submit claims for skin substitutes or radiopharmaceutical codes, learn how this new process will benefit you.
The Centers for Medicare & Medicaid Services (CMS) requires that any Medicare service provided or ordered must be authenticated by the author -- the one who provided or ordered that service. This article outlines acceptable forms of authentication.
When a medical reviewer contacts the provider requesting to submit an attestation statement or signature log to authenticate a medical record, the provider must submit the attestation statement or signature log within the following 20 calendar days. [CR 6698]
Payment will be considered for unused and discarded portions of a single-use drug/biological product. The JW modifier is not permitted when the actual dose of the drug or biological administered is less than the billing unit.
First Coast Service Options (First Coast) strives to ensure that the information available on our provider website is accurate, detailed, and current. Therefore, this is a dynamic site and its content changes daily. It is best to access the site to ensure you have the most current information rather than printing articles or forms that may become obsolete without notice.
